#1 Clinical Trials Search in Europe
Verified
High Ratings
80+ Specializations
210+ Therapies
Research Phase I/II/III

About Specializations

Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy in Warsaw specializes in nuclear medicine and clinical trials in cancer, heart, lung, and immune diseases.

Medical Center localisation

Ul. Szaserow 128
04-141 Warsaw, Poland

Want to learn more about this study or check if you can participate? Contact us.

Ongoing studies

  • Study on the Effectiveness of Infliximab, Tofacitinib, and Vedolizumab in Patients with Ulcerative Colitis Resistant to Initial Treatment

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Poland

  • Study on the Effectiveness of Etanercept and Methotrexate for Patients with Giant Cell Arteritis

    Recruiting

    2 1 1 1 1
    Investigated Drugs:
    Poland

  • Study on Long-term Safety of Nivolumab and Drug Combination for Cancer Patients from Previous BMS Trials

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Czechia France Germany Greece +4

  • Study of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium France Germany Greece Hungary +8

  • Study on the Use of SYN2, Adenosine, and Regadenoson for Diagnosing Coronary Artery Disease in Patients with Suspected Heart Conditions

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Finland Germany Italy The Netherlands Poland

  • Study on RVU120 and Venetoclax for Patients with Acute Myeloid Leukemia After Previous Treatment Failure

    Recruiting

    2 1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy Poland Spain

  • Study on Coronary Artery Disease: Evaluating Myocardial Blood Flow Using SYN2, Regadenoson, and Adenosine in Patients with Heart Conditions

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland

  • Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Belgium Czechia Denmark Estonia Finland +15

  • Study of MEN1703 and Glofitamab for Patients with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma

    Recruiting

    2 1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Poland Spain

  • Asthma in adults: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide compared with beclometasone dipropionate and formoterol fumarate dihydrate

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria France Germany Italy Poland Romania +2